205 related articles for article (PubMed ID: 12126464)
1. Can maitake MD-fraction aid cancer patients?
Kodama N; Komuta K; Nanba H
Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
[TBL] [Abstract][Full Text] [Related]
2. Several apparent errors surfaced on reading the article in the June 2002 issue of Alternative Medicine Review by Kodama et al. entitled "Can maitake MD-fraction aid cancer patients"?
Black W
Altern Med Rev; 2002 Dec; 7(6):451; author reply 452-4. PubMed ID: 12495370
[No Abstract] [Full Text] [Related]
3. Maitake extracts and their therapeutic potential.
Mayell M
Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
[TBL] [Abstract][Full Text] [Related]
4. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
[TBL] [Abstract][Full Text] [Related]
5. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
Kodama N; Komuta K; Nanba H
J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
[TBL] [Abstract][Full Text] [Related]
6. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
[TBL] [Abstract][Full Text] [Related]
7. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide).
Fullerton SA; Samadi AA; Tortorelis DG; Choudhury MS; Mallouh C; Tazaki H; Konno S
Mol Urol; 2000; 4(1):7-13. PubMed ID: 10851301
[TBL] [Abstract][Full Text] [Related]
9. Effect of Maitake D-fraction on cancer prevention.
Nanba H; Kubo K
Ann N Y Acad Sci; 1997 Dec; 833():204-7. PubMed ID: 9616756
[No Abstract] [Full Text] [Related]
10. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells.
Konno S
Vet Ther; 2004; 5(4):263-71. PubMed ID: 15719326
[TBL] [Abstract][Full Text] [Related]
11. The use of mushroom glucans and proteoglycans in cancer treatment.
Kidd PM
Altern Med Rev; 2000 Feb; 5(1):4-27. PubMed ID: 10696116
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with anticancer agents and OK-432.
Kimura I; Onoshi T; Takano J; Osawa H; Yasuhara S
Acta Med Okayama; 1974 Dec; 28(6):411-21. PubMed ID: 4142360
[No Abstract] [Full Text] [Related]
13. Chemotherapy of breast cancer. Investigational treatment.
Jones SE
Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
[No Abstract] [Full Text] [Related]
14. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of Peplomycin on recurrent breast cancer].
Kimura M; Koida T; Fukuda T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1665-9. PubMed ID: 6191688
[TBL] [Abstract][Full Text] [Related]
16. Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
Masuda Y; Yamashita S; Nakayama Y; Shimizu R; Konishi M
Biol Pharm Bull; 2024; 47(4):840-847. PubMed ID: 38616114
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostatic cancer cells: involvement of glyoxalase I.
Finkelstein MP; Aynehchi S; Samadi AA; Drinis S; Choudhury MS; Tazaki H; Konno S
J Altern Complement Med; 2002 Oct; 8(5):573-80. PubMed ID: 12470438
[TBL] [Abstract][Full Text] [Related]
18. [Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
Korman DB; Mikaélian SG; Boronovskaia LE; Maslova IA
Vopr Onkol; 2004; 50(2):202-7. PubMed ID: 15176224
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G
Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200
[TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.
Zhang M; Chiu LC; Cheung PC; Ooi VE
Oncol Rep; 2006 Mar; 15(3):637-43. PubMed ID: 16465424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
